Alzheimer Disease

Showing NaN - NaN of 61

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alzheimer Trial in United States (aripiprazole)

Completed
  • Alzheimer Disease
  • Rosemead, California
  • +5 more
Nov 7, 2013

Alzheimer Trial in Canada, United States (NS 2330 (Tesofensine))

Completed
  • Alzheimer Disease
  • NS 2330 (Tesofensine)
  • Mesa, Arizona
  • +86 more
Oct 28, 2013

Alzheimer Trial in Worldwide (Placebo, SAM-531 1.5 mg, SAM-531 3.0 mg)

Terminated
  • Alzheimer Disease
  • Placebo
  • +4 more
  • Phoenix, Arizona
  • +94 more
Dec 21, 2012

Alzheimer, Dementia Trial in United States (MPC-7869)

Completed
  • Alzheimer Disease
  • Dementia
  • Alabaster, Alabama
  • +132 more
May 3, 2009

Alzheimer Trial in Canada, United States (xaliproden (SR57746A))

Completed
  • Alzheimer Disease
  • xaliproden (SR57746A)
  • Birmingham, Alabama
  • +120 more
Aug 20, 2008

Alzheimer, Dementia Trial in Worldwide (MPC-7869)

Terminated
  • Alzheimer Disease
  • Dementia
  • Phoenix, Arizona
  • +91 more
Aug 1, 2008

Alzheimer Trial in Canada, United States (3APS)

Unknown status
  • Alzheimer Disease
  • Peoria, Arizona
  • +66 more
Feb 27, 2007

Dementia, Alzheimer Trial in United States (Skill Training Condition - problem solving training, REACH for TLC (Telephone Linked

Completed
  • Dementia
  • Alzheimer Disease
  • Skill Training Condition - problem solving training
  • REACH for TLC (Telephone Linked Computer) system
  • Birmingham, Alabama
  • +4 more
Sep 13, 2005

Alzheimer Trial in United States (Prednisone)

Completed
  • Alzheimer Disease
  • Birmingham, Alabama
  • +18 more
Jun 23, 2005

Alzheimer, Dyssomnias Trial in United States (Melatonin)

Completed
  • Alzheimer Disease
  • Dyssomnias
  • Tucson, Arizona
  • +30 more
Jun 23, 2005

Alzheimer Trial in United States (Trazodone, Haloperidol)

Completed
  • Alzheimer Disease
  • Los Angeles, California
  • +15 more
Jun 23, 2005